Clinical trial
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed…
NCT00246857 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Recruiting
Key facts
| NCT number | NCT00246857 |
|---|---|
| Title | Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death |
| Official title | Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Primary Immune Deficiency |
| Enrollment | 5,000 |
| Start date | Feb 12, 2007 |
| First posted | Oct 31, 2005 |
| Last update posted | Jan 21, 2026 |
| Countries | Turkey (Türkiye), United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: